We studied genes regulated by constitutively activated FGFR3 in two bladder tumor‐derived cell lines, MGH‐U3 and RT112, harboring an FGFR3 mutation (Y375C) and a fusion gene (FGFR3‐TACC3), respectively. This evidence concerns the gene TACC3 and urinary bladder neoplasm.